Prevena™ vs Dermabond in Groin Wound Infections in Vascular Surgery

Completed · Not applicable

Conditions studied: Wound Infection

In brief

This study evaluates the clinical efficacy and cost effectiveness of Prevena Incision Management System versus Dermabond in preventing groin wound infections in patients who undergo vascular surgery requiring a groin wound. Half of the patients will receive Dermabond and the other half will receive the Prevena Incision Management System for their groin wounds.

Key facts

Study ID

NCT02836990

Run by

State University of New York at Buffalo

People needed

105

Starts

2016-07-01

Expected to finish

2019-09-01

Last updated by the study team

2020-12-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• In need of elective vascular procedure requiring ≥8 cm groin incision.
• Able to provide consent
• Able to care for wound or have support person to complete wound care
• Willing to comply with follow-up

You may not qualify if…

• None

Where it is running

• Kaleida Health, Gates Vascular Institute — Buffalo, New York, United States
• State University of New York at Buffalo — Buffalo, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.